Remedium Lifecare gains on getting export order worth Rs 169 crore
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Remedium Lifecare is currently trading at Rs. 123.70, up by 1.65 points or 1.35% from its previous closing of Rs. 122.05 on the BSE.
The scrip opened at Rs. 117.00 and has touched a high and low of Rs. 128.00 and Rs. 112.35 respectively. So far 406037 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 179.66 on 02-Aug-2023 and a 52 week low of Rs. 9.18 on 28-Feb-2023.
Last one week high and low of the scrip stood at Rs. 153.00 and Rs. 112.35 respectively. The current market cap of the company is Rs. 1269.58 crore.
The promoters holding in the company stood at 1.11%, while Institutions and Non-Institutions held 0.04% and 98.85% respectively.
Remedium Lifecare has received export order worth Rs 169 crore from Pharmyka General Trading LLC, a Pharmaceutical company Situated in UAE. The order is for supply of pharmaceutical chemical. The order is to be executed between April 2024 to March 2025.
Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.
